The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

Epithelial Mesenchymal Transition ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Cell Phenotype ◽

First Line ◽

Mesenchymal Transition ◽

Therapeutic Implications ◽

Correlation of circulating tumor cell phenotypes based on epithelial-mesenchymal transition with prognosis in first-line chemotherapy of HER2-negative metastatic breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e24039 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e24039-e24039

Author(s):

Xiuwen Guan ◽

Fei Ma ◽

Chunxiao Li ◽

Shiyang Wu ◽

Shangying Hu ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cell ◽

Epithelial Mesenchymal Transition ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

First Line ◽

Mesenchymal Transition ◽

Cell Phenotypes ◽

Abstract P2-01-07: Effect of first-line chemotherapy in the expression of stemness and epithelial-to-mesenchymal transition markers in circulating tumor cells of patients with metastatic breast cancer.

10.1158/0008-5472.sabcs12-p2-01-07 ◽

2012 ◽

Author(s):

MA Papadaki ◽

G Kallergi ◽

D Mavroudis ◽

V Georgoulias ◽

PA Theodoropoulos ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Epithelial To Mesenchymal Transition ◽

Metastatic Breast ◽

First Line ◽

Mesenchymal Transition ◽

Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients

The Breast ◽

10.1016/j.breast.2017.01.007 ◽

2017 ◽

Vol 32 ◽

pp. 119-125 ◽

Cited By ~ 5

Author(s):

Xiao-ran Liu ◽

Bin Shao ◽

Jia-xi Peng ◽

Hui-ping Li ◽

Yan-lian Yang ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cell ◽

Prognostic Value ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Breast Cancer Patients ◽

First Line ◽

Cell Enumeration ◽

Epirubicin and vinorelbine versus single agent epirubicin as first line chemotherapy in metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80197-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S66-S67

Author(s):

B Ejlertsen

Keyword(s):

Breast Cancer ◽

Single Agent ◽

Metastatic Breast ◽

First Line ◽

First line chemotherapy of metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdj974 ◽

2006 ◽

Vol 17 ◽

pp. v165-v168 ◽

Cited By ~ 21

Author(s):

P. Pronzato ◽

M. Rondini

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

First Line ◽

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603096 ◽

2006 ◽

Vol 94 (9) ◽

pp. 1233-1236 ◽

Cited By ~ 21

Author(s):

C Pacilio ◽

◽

A Morabito ◽

F Nuzzo ◽

A Gravina ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Metastatic Breast ◽

Phase Iii ◽

First Line ◽

Single Centre ◽

Phase Iii Trial ◽

Luminal-like metastatic breast cancer: which is the room of endocrine maintenance therapy after first line chemotherapy?

Annals of Oncology ◽

10.1093/annonc/mdv336.03 ◽

2015 ◽

Vol 26 ◽

pp. vi3

Author(s):

S. Moroso ◽

M. Bonotto ◽

L. Gerratana ◽

G. Arpino ◽

C. De Angelis ◽

...

Keyword(s):

Breast Cancer ◽

Maintenance Therapy ◽

Metastatic Breast ◽

First Line ◽

First-line chemotherapy with or without biologic agents for metastatic breast cancer

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2010.01.007 ◽

2010 ◽

Vol 76 (2) ◽

pp. 99-111 ◽

Cited By ~ 23

Author(s):

Claudia Andreetta ◽

Alessandro M. Minisini ◽

Manuela Miscoria ◽

Fabio Puglisi

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Biologic Agents ◽

First Line ◽

Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women

Cancer Microenvironment ◽

10.1007/s12307-017-0194-9 ◽

2017 ◽

Vol 10 (1-3) ◽

pp. 25-37 ◽

Cited By ~ 6

Author(s):

Ritu Lakhtakia ◽

Adil Aljarrah ◽

Muhammad Furrukh ◽

Shyam S. Ganguly

Keyword(s):

Breast Cancer ◽

Epithelial Mesenchymal Transition ◽

Metastatic Breast ◽

Mesenchymal Transition

High dose proton pump inhibitor (PPI) in association with first line chemotherapy improves overall survival in patients with metastatic breast cancer

Frontiers in Pharmacology ◽

10.3389/conf.fphar.2014.61.00023 ◽

2014 ◽

Vol 5 ◽

Author(s):

Hu Xichun

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Metastatic Breast ◽

High Dose ◽

First Line ◽